Iradimed (NSDQ:IRMD) this week said it appointed Steven Kachelmeyer as VP of regulatory affairs and quality assurance, effective March 10.

Kachelmeyer will report directly to president and CEO Leslie McDonnell. He replaces Francis Casey who announced his intention to retire, effective June 30.

“Under Fran’s leadership, Iradimed gained regulatory approvals in the U.S., Europe and many other countries for the world’s only non-magnetic MRI compatible infusion pump and patient vital signs monitor,” McDonnell said in a news release. “On behalf of the Board of Directors and everyone at Iradiment, I would like to congratulate Fran on his retirement and thank him for originating and guiding our regulatory function, providing many key contributions to the success of the company.”

Prior to joining Iradimed, Kachelmeyer was the executive director of regulatory and quality affairs at Merz North America. He also held leadership roles at GE Healthcare for over 30 years.

“Steve is a deeply experienced regulatory and quality executive in the medical technology industry. I am confident he will continue to build a world-class regulatory and quality system to support our rapid growth. We are excited to add him to the executive team,” McDonnell said.